3D-OSEM and FP-CIT SPECT quantification: benefit for studies with a high radius of rotation?
暂无分享,去创建一个
[1] P B Hoffer,et al. Computerized three-dimensional segmented human anatomy. , 1994, Medical physics.
[2] Joachim Hornegger,et al. Isotropic reconstruction of SPECT data using OSEM3D: correlation with CT. , 2006, Academic radiology.
[3] A. Graybiel,et al. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. , 1999, Brain : a journal of neurology.
[4] S. Kish,et al. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.
[5] Jan Booij,et al. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism , 2001, European Journal of Nuclear Medicine.
[6] Preliminary monte carlo study of 18F-FDG SPECT imaging with LaBr3:Ce Crystal-based Gamma Cameras , 2010, 2010 Annual International Conference of the IEEE Engineering in Medicine and Biology.
[7] G. Zettinig,et al. Measuring the rate of progression of Parkinson's disease over a 5‐year period with β‐CIT SPECT , 2003, Movement disorders : official journal of the Movement Disorder Society.
[8] John S Fleming,et al. The specific uptake size index for quantifying radiopharmaceutical uptake. , 2004, Physics in medicine and biology.
[9] Andy Adler,et al. A neural network image reconstruction technique for electrical impedance tomography , 1994, IEEE Trans. Medical Imaging.
[10] A. Lees,et al. Ageing and Parkinson's disease: substantia nigra regional selectivity. , 1991, Brain : a journal of neurology.
[11] Wolfgang A. Weber,et al. Image Quality and Data Quantification in Dopamine Transporter SPECT: Advantage of 3-Dimensional OSEM Reconstruction? , 2012, Clinical nuclear medicine.
[12] W. Koch,et al. Loss of dopamine transporter binding in Parkinson's disease follows a single exponential rather than linear decline. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] O. Pogarell,et al. Striatal dopamine transporter binding in early to moderately advanced Parkinson's disease: monitoring of disease progression over 2 years , 2001, Nuclear medicine communications.
[14] M. Ljungberg,et al. SIMIND Monte Carlo simulation of a single photon emission CT , 2010, Journal of medical physics.
[15] Mona Mustafa,et al. Influence of movement on FP-CIT SPECT quantification: a Monte Carlo based simulation , 2007, Nuclear medicine communications.
[16] A. Brück,et al. Simple Ratio Analysis of 18F-Fluorodopa Uptake in Striatal Subregions Separates Patients with Early Parkinson Disease from Healthy Controls , 2009, Journal of Nuclear Medicine.
[17] Robert B. Innis,et al. Iodine-123-β-CIT and Iodine-123-FPCIT SPECT Measurement of Dopamine Transporters in Healthy Subjects and Parkinson's Patients , 1998 .
[18] Werner Poewe,et al. Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice , 2003, Movement disorders : official journal of the Movement Disorder Society.
[19] S Ted Treves,et al. Pediatric 99mTc-MDP bone SPECT with ordered subset expectation maximization iterative reconstruction with isotropic 3D resolution recovery. , 2010, Radiology.
[20] J. Seibyl,et al. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] S Ted Treves,et al. Pediatric 99mTc-DMSA SPECT performed by using iterative reconstruction with isotropic resolution recovery: improved image quality and reduced radiopharmaceutical activity. , 2009, Radiology.
[22] Michael Ljungberg,et al. Monte Carlo Calculation in Nuclear Medicine: Applications in Diagnostic Imaging , 2012 .
[23] J. Unterrainer,et al. Measuring the progression of idiopathic Parkinson's disease with [123I] β-CIT SPECT , 2000, Journal of Neural Transmission.
[24] Walter Koch,et al. Cross-camera comparison of SPECT measurements of a 3-D anthropomorphic basal ganglia phantom , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[25] W. Oertel,et al. Role of dopamine transporter SPECT for the practitioner and the general neurologist , 2003, Movement disorders : official journal of the Movement Disorder Society.
[27] Anne Larsson,et al. Rotation Radius Dependence of 123I-FP-CIT and 123I-IBZM SPECT Uptake Ratios: A Monte Carlo Study , 2012, The Journal of Nuclear Medicine Technology.
[28] J. Darcourt,et al. Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database , 2013, European Journal of Nuclear Medicine and Molecular Imaging.
[29] Michael Ljungberg,et al. The SIMIND Monte Carlo program , 2012 .
[30] Willibald Gerschlager,et al. Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: A longitudinal β‐CIT SPECT study , 2002, Movement disorders : official journal of the Movement Disorder Society.
[31] M. Ljungberg,et al. A new collimator simulation in SIMIND based on the Delta-Scattering technique , 2004, IEEE Symposium Conference Record Nuclear Science 2004..
[32] W. Koch,et al. Equipment-independent reference values for dopamine transporter imaging with 123I-FP-CIT , 2007, Nuklearmedizin.
[33] S. Gacinovic,et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]‐FP‐CIT SPECT imaging: The [123I]‐FP‐CIT study group , 2000, Movement disorders : official journal of the Movement Disorder Society.
[34] K. Ogawa,et al. A practical method for position-dependent Compton-scatter correction in single photon emission CT. , 1991, IEEE transactions on medical imaging.
[35] D. Grosset,et al. Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders , 2003, Movement disorders : official journal of the Movement Disorder Society.
[36] H. Malcolm Hudson,et al. Accelerated image reconstruction using ordered subsets of projection data , 1994, IEEE Trans. Medical Imaging.
[37] Perry E Radau,et al. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[38] John S. Fleming,et al. Quantification of [123I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[39] Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression. , 2002, JAMA.
[40] A Pupi,et al. European Association of Nuclear Medicine procedure guidelines for brain neurotransmission SPET using (123)I-labelled dopamine D(2) transporter ligands. , 2002, European journal of nuclear medicine and molecular imaging.
[41] Perry E. Radau,et al. Does combined imaging of the pre- and postsynaptic dopaminergic system increase the diagnostic accuracy in the differential diagnosis of parkinsonism? , 2007, European Journal of Nuclear Medicine and Molecular Imaging.